Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity ...
The company's financial results should remain strong for a while. Analysts expect earnings per share (EPS) to grow at an ...
First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof ...
Last week, U.S. consumer groups and labour unions petitioned the U.S. Federal Trade Commission to block Novo Holdings, the ...
Moving ahead, Rob Rowe, Regional Research Director and Head of Global Strategy at a large US bank is ‘ tactically bullish ’ on the back of continuing tech recovery and the markets “pricing in a soft ...
As more Big Pharma companies have launched direct-to-consumer telehealth platforms, lawmakers have raised concerns they might ...
On July 1, IUPUI was split into Indiana University Indianapolis and Purdue University in Indianapolis. Purdue’s Indianapolis ...
Hosted on MSN1d
Thousands of Antidepressant Bottles Were Recalled Over 'Impurity' Risk: Here's More ContextThe FDA recalled delayed-release capsules of duloxetine because they contain nitrosamines, which are everywhere but can be ...
In our latest round-up, we look at Amazon being set to launch ‘Low-Cost Store’, Arm cancelling an IP licence with Qualcomm, ...
Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets ...
Eli Lilly (LLY) said a study of its drug Ebglyss showed it was able to improve skin and itch in patients with atopic ...
New results show Eli Lilly’s Ebglyss improved skin and itch among patients with moderate-to-severe atopic dermatitis who were previously treated with dupilumab. These results fr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback